Login

Forgot password?
Sign up today and your first download is free.
REGISTER

Food Safety

April 05, 2021 | Daily News

Supplement industry lawyers say FDA has stepped up its oversight of dietary supplements and they predict that oversight will become even stronger under the Biden administration, but leading supplement lobbyists are optimistic that at the state level the strict chain of production approach used by California won’t spread to other states and could even be ratcheted back by courts in California.

March 31, 2021 | Daily News

HHS on Tuesday (March 30) pinpointed several FDA food regulations it would like to advance in the “foreseeable future,” including rules that would update the definition of the claim “healthy” on food labels, remove the “generally recognized as safe” designation from partially hydrogenated oils, and update standards of identity for low- and nonfat yogurt.

March 26, 2021 | Daily News

FDA watchers are split over how newly minted HHS Secretary Xavier Becerra will address the battle between FDA and the U.S. Department of Agriculture over which agency should have authority to regulate genetically engineered food animals.

March 25, 2021 | Daily News

Former FDA Commissioner Scott Gottlieb believes Congress needs to craft legislation that lays out a framework under which cannabidiol can be included in foods and dietary supplements, as FDA likely won’t be able to push regulation out fast enough to keep up with the industry’s growth.

March 17, 2021 | Daily News

The House has delayed votes on three bipartisan drug-pricing and food safety bills that were originally slated to be taken up this week, a Democratic leadership aide told Inside Health Policy.

March 15, 2021 | Daily News

The House this week will consider three bipartisan drug-pricing and food safety bills, two of which aim to increase competition and lower drug prices by more narrowly defining the types of new drugs that can receive five years of exclusivity and by increasing education in biologics and biosimilars.

March 09, 2021 | Daily News

A coalition of health and consumer advocacy organizations on Tuesday (March 9) filed suit against HHS over a Trump-era rule that requires health agency regulations be assessed every 10 years or be automatically scrapped.

March 03, 2021 | Daily News

The Center for Food Safety wants U.S. Department of Agriculture chief Tom Vilsack and HHS Secretary-nominee Xavier Becerra to overturn a controversial memorandum of understanding, signed in the last days of the Trump administration, that transferred most of the regulatory authority over genetically modified animals from FDA to USDA.

January 22, 2021 | Daily News

The White House Office of Management and Budget pulled six FDA guidances and rules from its review, a move prompted by President Joe Biden’s freeze on all regulations issued by the Trump administration that have not yet gone into effect.

January 19, 2021 | Daily News

FDA chief Stephen Hahn blasted an 11th-hour agreement that HHS penned with the U.S. Department of Agriculture shifting FDA’s regulation of animal food biotechnology products to USDA, with the outgoing FDA head vowing his agency will continue to oversee genetically modified animals intended for human consumption.

November 17, 2020 | Daily News

Bipartisan bills calling for generic drug labeling updates, an end to gaming of certain orphan drug exclusivity provisions and an updated list of major allergens are among 10 health care measures that were passed by the House on Tuesday (Nov. 17).

October 20, 2020 | Daily News

A non-profit food safety group worries FDA’s decision to move forward on its own to develop a common name for cell-based seafood could lead to a more favorable marketplace for those products than for cell-based meat and poultry, for which FDA and the U.S. Department of Agriculture are jointly developing common names.

September 21, 2020 | Daily News

FDA proposed a rule Monday (Sept. 21) that aims to improve food traceability by directing companies that manufacture, process or pack foods included on the agency’s new Food Traceability List (FTL) to create and maintain records containing key data elements associated with critical tracking events

September 04, 2020 | Daily News

Four key dietary supplement industry groups are throwing their support behind a bipartisan House bill that would allow hemp-derived cannabidiol and any other hemp-derived ingredient to be used in dietary supplements.

August 04, 2020 | Daily News

Two major hemp industry groups are urging the White House to ensure FDA’s long-awaited cannabidiol enforcement guidance provides enforcement discretion for CBD-containing consumer products.

July 29, 2020 | Daily News

FDA announced Wednesday (July 29) that it will decrease application costs for its prescription drug user fee program in fiscal 2021, but it will increase overall program fees by about $11,000 over fiscal 2020 levels, for a total of about $336,000.

July 24, 2020 | Daily News

The House on Friday (July 24) passed 224-189 an FDA spending package that would give the agency $3.21 billion in discretionary funding, an increase of $40.8 million over fiscal 2020 funding levels, and would provide the agency authority to recall drugs.

July 15, 2020 | Daily News

The House Energy & Commerce Committee on Wednesday (July 15) passed five bipartisan FDA policy bills that would increase the agency’s authority over imported counterfeit medical devices, stop gaming of certain orphan drug exclusivity provisions, boost use of continuous manufacturing, empower FDA to require labeling updates for generic drugs, and allow the agency to add food ingredients to the list of major allergens.

July 13, 2020 | Daily News

FDA released a promised “new era” food safety blueprint Monday (July 13) that builds on the Food Safety Modernization Act to enhance traceability, create tools to combat foodborne illnesses, modernize business models and foster a new culture of food safety based on lessons learned during the pandemic.

July 08, 2020 | Daily News

The White House Office of Management and Budget last week completed its review of FDA’s draft guidance on quality considerations for clinical research on cannabis.

Pages